High H. pylori cure rate for nonbismuth quadruple Tx

High <i>H. pylori</i> cure rate for nonbismuth quadruple tx
Optimized nonbismuth quadruple regimens, either hybrid or concomitant, have a cure rate of more than 90 percent for Helicobacter pylori infections, according to a study published in the July issue of Gastroenterology.

(HealthDay)—Optimized nonbismuth quadruple regimens, either hybrid or concomitant, have a cure rate of more than 90 percent for Helicobacter pylori (H. pylori) infections, according to a study published in the July issue of Gastroenterology.

Javier Molina-Infante, M.D., from the Hospital San Pedro de Alcantara in Caceres, Spain, and colleagues compared the efficacy of two optimized nonbismuth quadruple regimens among 343 consecutive individuals with H. pylori infection. Participants were randomized to receive hybrid therapy ( and , twice daily for 14 days, plus clarithromycin and nitroimidazole twice daily for final seven days) or concomitant therapy (same drugs taken concurrently, twice daily for 14 days).

The researchers found that rates of eradication for hybrid and concomitant therapies were 92 and 96.1 percent, respectively (P = 0.07), in per-protocol analysis. The rates were 90 and 91.7 percent, respectively (P = 0.35) in intention-to-treat analysis. Full compliance was high at 95.5 percent. H. pylori strains that were resistant to clarithromycin, , and both drugs were seen in 23.5, 33, and 8.8 percent of patients, respectively. Nearly half (51.5 percent) of patients reported mild side effects. The only significant predictor of eradication was compliance greater than 80 percent (odds ratio, 12.5). Compliance was significantly higher for hybrid therapy versus concomitant therapy (98.8 versus 95.2 percent; P = 0.05).

"Optimized nonbismuth quadruple hybrid and concomitant therapies cured more than 90 percent of patients with H. pylori infections in areas of high and metronidazole resistance," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Kidney-brain connection may help drive chronic kidney disease

11 hours ago

In addition to affecting blood pressure, high-salt intake can promote kidney function decline in patients with chronic kidney disease. A study appearing in an upcoming issue of the Journal of the American Society of Nephrology (J ...

Flu's grip on U.S. starting to weaken: CDC

11 hours ago

(HealthDay)—After a rough start to the flu season, the number of infections seems to have peaked and is even starting to decline in many parts of the nation, federal health officials reported Thursday.

Litchi fruit suspected in mystery illness in India

11 hours ago

A mysterious and sometimes fatal brain disease that has afflicted children in northeastern India for years could be linked to a toxic substance in litchi fruits, US researchers said Thursday.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.